Semaglutide might be better for you if You have type 2 diabetes (additional blood sugar benefits) You prefer a medication with longer clinical history You want proven, consistent results Insurance covers semaglutide but not tirzepatide Tirzepatide might be better for you if You want potentially greater weight loss Youve tried semaglutide without optimal results You have both weight and blood sugar concerns You can tolerate potentially higher initial costs Both medications work best for people who Have a BMI of 30 or higher (or 27+ with weight-related health conditions) Are committed to lifestyle changes Can handle weekly injections Want non-surgical weight loss treatment
Your physician will conduct a comprehensive assessment, considering your medical history, current health status, and other relevant factors to determine suitability for weight-loss medication and CDPHP coverage
Although Semaglutide offers benefits outside of pregnancy, such as weight loss and blood sugar regulation, these benefits do not translate directly to pregnancy without substantial risk
Semaglutide -related nausea typically peaks 24 to 48 hours after injection and gradually improves over the following days
#longevity #geroscience #pulmonaryhypertension #biotech #aging 35Pharma To view or add a comment, sign in Insulin Icodec = Once-Weekly Insulin Revolution Remember it with this mnemonic: I-C-O-D-E-C I = Inject once weekly C = Convenience improved (fewer injections, better adherence) O = Optimized glycemic control D = Designed for long duration (7-day basal coverage) E = Eases treatment burden C = Changing diabetes care Insulin icodec is a novel once-weekly basal insulin analog developed to simplify diabetes management and potentially improve adherence compared with daily basal insulin regimens
:max_bytes(150000):strip_icc()/GettyImages-758312269-e8f09e45f7614626a9526273bb03c1fc.jpg)
